GlassScriptGore Viabil Biliary Endoprosthesis
Payments companies reported to CMS as associated with Gore Viabil Biliary Endoprosthesis. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Gore Viabil Biliary Endoprosthesis, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Gore Viabil Biliary Endoprosthesis
These are the largest totals companies reported as associated with Gore Viabil Biliary Endoprosthesis. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Todd Baron | Rochester, MN | Gastroenterology (Internal Medicine) | $27,815.63 |
| Shayan Irani | Seattle, WA | Gastroenterology (Internal Medicine) | $12,999.43 |
| Rushikesh Shah | Dallas, TX | Gastroenterology (Internal Medicine) | $10,192.71 |
| Ramana Yedavalli | Joliet, IL | Vascular & Interventional Radiology | $2,025.00 |
| Jean Bismuth | Houston, TX | Vascular Surgery | $149.54 |
| David Maldow | Ithaca, NY | Vascular & Interventional Radiology | $137.86 |
| Noelle Mcnaught | Charlotte, NC | Medical | $114.14 |
| Atul Gupta | Rochester, NY | Diagnostic Radiology | $99.04 |
| Michael Muhlert | Memphis, TN | Vascular & Interventional Radiology | $73.03 |
| Mark Choiniere | Memphis, TN | Physician Assistant | $73.02 |
Prescribed Gore Viabil Biliary Endoprosthesis?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.